Roxithromycin and ambroxol hydrochloride dispersible tablets

Roxithromycin and ambroxol hydrochloride dispersible tablets

  • CN 101,485,673 B
  • Filed: 02/11/2009
  • Issued: 08/11/2010
  • Est. Priority Date: 02/11/2009
  • Status: Active Grant
First Claim
Patent Images

1. roxithromycin and ambroxol hydrochloride dispersible tablets, count by weight percentage, Roxithromycin 50~

  • 60%, ambroxol hydrochloride 10~

    20%, filler 18~

    25%, disintegrating agent 10~

    15%, binding agent 0.1~

    1%, lubricant 1~

    5%, and described filler is a microcrystalline Cellulose, described disintegrating agent is a polyvinylpolypyrrolidone, and described binding agent is a hypromellose.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×